CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants

被引：2
|
作者：
Villalba, N
Pérez-Olmeda, M
de José, M
Hernández, M
Sirera, R
Español, T
González-Molina, A
Soriano, V
机构：
[1] Inst Salud Carlos III, Infect Dis Serv, E-28010 Madrid, Spain
[2] Hosp La Paz, Serv Pediat, Madrid, Spain
[3] Hosp La Fe, Serv Immunol, E-46009 Valencia, Spain
[4] Hosp Vall Hebro, Serv Immunol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1999年 / 18卷 / 05期
关键词：
D O I：
10.1007/PL00015029
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页码：389 / 391
页数：3
相关论文
共 50 条
  • [41] Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents
    Tuttle, DL
    Coberley, CR
    Xie, XM
    Kou, ZC
    Sleasman, JW
    Goodenow, MM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (03) : 305 - 313
  • [42] SURVIVAL IN CHILDREN WITH PERINATALLY ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION
    SCOTT, GB
    HUTTO, C
    MAKUCH, RW
    MASTRUCCI, MT
    OCONNOR, T
    MITCHELL, CD
    TRAPIDO, EJ
    PARKS, WP
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (26): : 1791 - 1796
  • [43] TALEN-Mediated Knockout of CCR5 Confers Protection Against Infection of Human Immunodeficiency Virus
    Shi, Bingjie
    Li, Juan
    Shi, Xuanling
    Jia, Wenxu
    Wen, Yi
    Hu, Xiongbing
    Zhuang, Fengfeng
    Xi, Jianzhong
    Zhang, Linqi
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 (02) : 229 - 241
  • [44] CCR5 genotype and the clinical course of HIV-1 infection
    Scribner, CL
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (09) : 780 - 780
  • [45] Care of the Child Perinatally Exposed to Human Immunodeficiency Virus
    Wedderburn, Catherine J.
    Musiime, Grace M.
    Mchenry, Megan S.
    CLINICS IN PERINATOLOGY, 2024, 51 (04) : 881 - 894
  • [46] Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency virus type I infection and pulmonary tuberculosis: Implications for pathogenesis
    Shalekoff, S
    Pendle, S
    Johnson, D
    Martin, DJ
    Tiemessen, CT
    JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (06) : 390 - 401
  • [47] Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection
    Veazey, RS
    Klasse, PJ
    Ketas, TJ
    Reeves, JD
    Piatak, M
    Kunstman, K
    Kuhmann, SE
    Marx, PA
    Lifson, JD
    Dufour, J
    Mefford, M
    Pandrea, I
    Wolinsky, SM
    Doms, RW
    DeMartino, JA
    Siciliano, SJ
    Lyons, K
    Springer, MS
    Moore, JP
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (10): : 1551 - 1562
  • [48] GATA-1 transcription factor transactivates the promoter for CCR5, a coreceptor for human immunodeficiency virus type 1 entry
    Moriuchi, M
    Moriuchi, H
    Fauci, AS
    BLOOD, 1999, 93 (04) : 1433 - 1435
  • [49] A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1
    Siciliano, SJ
    Kuhmann, SE
    Weng, YM
    Madani, N
    Springer, MS
    Lineberger, JE
    Danzeisen, R
    Miller, MD
    Kavanaugh, MP
    DeMartino, JA
    Kabat, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) : 1905 - 1913
  • [50] CCRS/△ccr5 heterozygosity:: A selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype
    D'Aquila, RT
    Sutton, L
    Savara, A
    Hughes, MD
    Johnson, VA
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06): : 1549 - 1553
12345